Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
epidemiology health policy Position paper Measles
Download:
Recommendation Spain Diphtheria
Download:
epidemiology health policy Rotavirus
Download:
Recommendation United States of America Diphtheria
Download:
health policy United Kingdom Rotavirus
Download: